Gerard Aragonès

Dr. Gerard Aragonès

Universitat Rovira i Virgili, Department of Biochemistry and Biotechnology, Nutrigenomics Research Group, Tarragona, Spain
orcid

Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
31 January 2013 in Cell Cycle
Verified
Journal Article
Open access
Javier A. MenendezJavier A. Menendez
Javier A. Menendez
Jorge JovenJorge Joven
Jorge Joven
Gerard AragonèsGerard Aragonès
Gerard Aragonès
Enrique Barrajon-CatalanEnrique Barrajon-Catalan
Enrique Barrajon-Catalan
Raúl Beltrán-DebónRaúl Beltrán-Debón
Raúl Beltrán-Debón
Antonio Segura-CarreteroAntonio Segura-Carretero
Antonio Segura-Carretero
Aging can be viewed as a quasi-programmed phenomenon driven by the overactivation of the nutrient-sensing mTOR gerogene. mTOR-driven aging can be triggered or accelerated by a decline or loss of re...

1 February 2012 in Phytomedicine
Verified
Journal Article
Closed access
Maria Herranz-LopezMaria Herranz-Lopez
Maria Herranz-Lopez
SFSalvador Fernández-Arroyo
Salvador Fernández-Arroyo
APAlmudena Pérez-Sanchez
Almudena Pérez-Sanchez
Enrique Barrajon-CatalanEnrique Barrajon-Catalan
Enrique Barrajon-Catalan
Raúl Beltrán-DebónRaúl Beltrán-Debón
Raúl Beltrán-Debón
Vicente MicolVicente Micol
Vicente Micol

13 January 2016 in BioFactors
Verified
Journal Article
Closed access
CBCinta Bladé
Cinta Bladé
Gerard AragonèsGerard Aragonès
Gerard Aragonès
Anna Arola-ArnalAnna Arola-Arnal
Anna Arola-Arnal
BMBegoña Muguerza
Begoña Muguerza
Francisca Isabel BravoFrancisca Isabel Bravo
Francisca Isabel Bravo
Manuel SuárezManuel Suárez
Manuel Suárez

1 July 2012 in Biochimica et Biophysica Acta (BBA) - General Subjects
Verified
Journal Article
Closed access
Jorge JovenJorge Joven
Jorge Joven
EEEugenia Espinel
Eugenia Espinel
Anna RullAnna Rull
Anna Rull
Gerard AragonèsGerard Aragonès
Gerard Aragonès
EGEsther Rodríguez Gallego
Esther Rodríguez Gallego
Raúl Beltrán-DebónRaúl Beltrán-Debón
Raúl Beltrán-Debón

1 January 2010 in Mediators of Inflammation
Verified
Journal Article
Open access
PDF file
Anna RullAnna Rull
Anna Rull
JCJordi Camps
Jordi Camps
CACarlos Alonso-Villaverde
Carlos Alonso-Villaverde
Jorge JovenJorge Joven
Jorge Joven
To maintain homeostasis under diverse metabolic conditions, it is necessary to coordinate nutrient-sensing pathways with the immune response. This coordination requires a complex relationship between cells, hormones, and cytokines in which inflammatory and metabolic pathways are convergent at multiple levels. Recruitment of macrophages to metabolically compromised tissue is a primary event in which chemokines play a crucial role. However, chemokines may also transmit cell signals that generate multiple responses, most unrelated to chemotaxis, that are involved in different biological processes. We have reviewed the evidence showing that monocyte chemoattractant protein-1 (MCP-1 or CCL2) may have a systemic role in the regulation of metabolism that sometimes is not necessarily linked to the traffic of inflammatory cells to susceptible tissues. Main topics cover the relationship between MCP-1/CCL2, insulin resistance, inflammation, obesity, and related metabolic disturbances.

1 January 2014 in Critical Reviews in Food Science and Nutrition
Verified
Journal Article
Closed access
Jorge JovenJorge Joven
Jorge Joven
Vicente MicolVicente Micol
Vicente Micol
Antonio Segura-CarreteroAntonio Segura-Carretero
Antonio Segura-Carretero
CACarlos Alonso-Villaverde
Carlos Alonso-Villaverde
Javier A. MenendezJavier A. Menendez
Javier A. Menendez
FPFor The Bioactive Food Components Platform
For The Bioactive Food Components Platform
Plant-derived dietary polyphenols may improve some disease states and promote health. Experimental evidence suggests that this is partially attributable to changes in gene expression. The rational use of bioactive food components may therefore present an opportunity to activate or repress selected gene expression pathways and, consequently, to manage or prevent disease. It remains to be determined whether this use of bioactive food components can be done safely. This article reviews the associated controversies and limitations of polyphenol therapy. There is a paucity of clinical data on the rational use of polyphenols, including a lack of knowledge on effective dosage, actual chemical formulations, bioavailability, distribution in tissues, the effect of genetic variations, differences in gut microflora, the synergistic (or antagonistic) effects observed in extracts, and the possible interaction between polyphenols and lipid domains of cell membranes that may alter the function of relevant receptors. The seminal question of why plants make substances that benefit humans remains unanswered, and there is still much to learn in terms of correlative versus causal effects of human exposure to various nutrients. The available data strongly suggest significant effects at the molecular level that represent interactions with the epigenome. The advent of relatively simple technologies is helping the field of epigenetics progress and facilitating the acquisition of multiple types of data that were previously difficult to obtain. In this review, we summarize the molecular basis of the epigenetic regulation of gene expression and the epigenetic changes associated with the consumption of polyphenols that illustrate how modifications in human nutrition may become relevant to health and disease.